undefined undefined
NaN.000
NaN.00%
GLOBAL MARKETS-Stocks, bitcoin regain some ground along with precious metals Updates prices for U.S. trading session Wall Street stocks regain some footing Yen edges up against greenback with Japanese election in focus Cryptocurrencies rebound after steep losses Oil rises as U.S.-Iran talks get star
02-07 01:49
BRIEF-Stellantis Resets Business, Books $22 Bln Charge Feb 6 (Reuters) - Stellantis NV STLAM.MI : STELLANTIS RESETS ITS BUSINESS TO MEET CUSTOMER PREFERENCES AND TO SUPPORT PROFITABLE GROWTH ANNOUNCES €22 BILLION CHARGES FOR STRATEGIC SHIFT SUSPENDS DIVIDEND, AUTHORIZES €5 BILLION HYBRID BONDS TO I
02-06 15:12
Take-Two beats Q3 revenue expectations, ups FY net bookings forecast Overview Video game publisher's Q3 net bookings rose 28% to $1.76 bln, above co's guidance range Q3 GAAP net revenue was $1.70 bln, beating analysts' expectations Company raised fiscal year 2026 net bookings outlook to $6.65-$6.7 b
02-04 05:15
BRIEF-MPLX LP Reports Q4 Results Feb 3 (Reuters) - MPLX LP MPLX.N : MPLX Q4 NET INCOME USD 1,193 MILLION MPLX Q4 PRETAX PROFIT USD 1,206 MILLION MPLX Q4 INCOME FROM OPERATIONS USD 1,483 MILLION MPLX Q4 OPERATING EXPENSES USD 419 MILLION MPLX Q4 ADJUSTED EBITDA USD 1,804 MILLION VERSUS. IBES ESTIMATE
02-03 21:19
UPDATE 1-AmEx projects upbeat 2026 profit as affluent spending holds up AmEx sees 2026 profit, revenue largely above expectations CFO touts focus on younger and premium consumers Strong holiday shopping season boosts Q4 revenue Shares fall as investors digest marginal Q4 profit miss Rewrites through
01-30 23:00
BUZZ-Street View: Mastercard in high gear following extended partnership with Capital One ** Mastercard MA.N beat Wall Street’s Q4 profit expectations on solid consumer spending and said it will cut about 4% of its global staff to shift investments ** Co said it extended its U.S. and Canada partners
01-30 21:29
ALX Oncology Reports CD47 Biomarker Predicts Response to Evorpacept in Advanced HER2-Positive Breast Cancer ALX Oncology Holdings Inc. has announced new data from a Phase 1b/2 clinical trial evaluating its investigational CD47-inhibitor evorpacept in combination with Jazz Pharmaceuticals' zanidatama
01-30 21:15
UPDATE 4-Mastercard profit exceeds expectations, set to lay off 4% globally Adds details on job cuts in paragraphs 1 to 4 By Utkarsh Shetti Jan 29 (Reuters) - Mastercard MA.N beat Wall Street expectations for fourth-quarter profit on resilient spending, and said it will lay off about 4% of its globa
01-29 21:08
UPDATE 3-Mastercard profit beats estimates on sustained consumer spending Updates with comparisons throughout Jan 29 (Reuters) - Mastercard MA.N beat Wall Street expectations for fourth-quarter profit on Thursday, as resilient spending on travel, leisure and everyday essentials boosted transaction v
01-29 21:08
Tractor Supply Q4 sales miss estimates as discretionary demand softens Overview Rural lifestyle retailer's Q4 net sales rose 3.3% but missed analyst expectations Q4 diluted EPS was $0.43, in line with previous year Company opened 31 new Tractor Supply stores and one new Petsense store in Q4 Outlook
01-29 20:03